| Disgren (triflusal) / Uriach Pharma |
NCT01612273: The Effect of Triflusal on Peripheral Microcirculation Dysfunction |
|
|
| Completed | 4 | 92 | RoW | Triflusal, Disgren®, Aspirin, Astrix | Yonsei University | Vasospastic Syndrome | 01/13 | 06/13 | | |
MAESTRO, NCT01174693: Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping |
|
|
| Completed | 4 | 795 | RoW | Triflusal, Disgren®, Clopidogrel, Plavix® | Gangnam Severance Hospital, Myung In Pharmaceutical Company, Yonsei University | Cerebral Infarction | 12/14 | 03/15 | | |
2007-004290-26: Evaluación del tratamiento con triflusal en pacientes con cardiopatía isquémica estable con no respuesta a AAS |
|
|
| Ongoing | 4 | 80 | Europe | Disgren 600 mg polvo y disolvente para solución oral, Disgren 600 mg polvo y disolvente para solución oral | J. Uriach y Compañía, S.A | Profilaxis antiagregante en pacientes con cardiopatía isquémica estable | | | | |
| Completed | 4 | 1220 | Europe | Aspirin, Salospir, Triflusal, Aflen | University of Ioannina | Atherothrombosis | 02/17 | 03/18 | | |
